Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists decode how amputees re-learn to walk

NCT ID NCT06780943

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how people with a leg amputation adjust their walking patterns. Researchers will measure body movements, muscle activity, and balance in 75 participants while they walk on different surfaces. The goal is to better understand these adaptations, which could help improve prosthetic design and rehabilitation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 75 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2025

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Person with unilateral transtibial or transfemoral amputation and healthy volunteers for control population.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * The patient must have given their free and informed consent and signed the consent form * The patient must be a member or beneficiary of a health insurance plan * Persons with unilateral transtibial or transfemoral amputees followed in the MPR department at the Nîmes University Hospital, RRL department, Grau du Roi University Rehabilitation Hospital. * All etiologies: vascular, traumatic and septic. * Adapted equipment validated by the rehabilitation doctor. * Able to walk for 5 minutes on a treadmill without technical assistance Inclusion criteria specific to healthy volunteers: * Adults (\>18 years old) and under 40 years old * Able to walk for 5 minutes on a treadmill without technical assistance. * Body mass index between 18 and 25 Exclusion Criteria: * The patient is participating in an interventional or a drug/medical device study, or is in a period of exclusion determined by a previous study * The patient unable to express consent * It is impossible to give the patient informed information * The patient is under safeguard of justice or state guardianship * Patient who has already been included in this study. * Pregnant, parturient or breastfeeding patient. * Appearance of a stump wound during the study requiring unloading. * Patient for whom the implementation of vibration stimulation is not possible Exclusion criteria for amputee patients: * Patient suffering from uncorrected or untreated visual disorders. * Patient with major cognitive disorders (MoCA \<23). * Patient with vestibular disorders or uncontrolled epilepsy. * Patient with an unhealed amputation stump. * Patient with a weight \> 135kg or \< 20kg * Patients with a FAC of 1 (i.e. patients who need firm and continuous assistance from a person to support their weight and maintain balance) or less. * Sensory impairment that makes it impossible to perceive stimulation * Significantly reduced bone density * Patient in whom it is impossible to correctly adjust the GRAIL System harness to the corresponding body part due to: * Body shape * Colostomy bags * Skin lesions that cannot be adequately protected. * Any other reason that prevents a good, painless adjustment of the harness. * Patient in whom it is impossible to correctly adjust the CON-TREX System: * Body shape * Colostomy bags * Skin lesions that cannot be adequately protected. * Any other reason that prevents a good, painless adjustment of the support systems. Exclusion criteria for healthy volunteers: * History of significant injury or surgery affecting the lower limbs (such as hip or knee replacement or knee/ankle ligament reconstruction) that could impact walking * History of neurological or psychiatric disorders that could affect locomotion or the processing of sensorimotor information. * Drug treatments affecting locomotion: drugs likely to alter walking or balance, such as sedatives, muscle relaxants or neuroleptics.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Amputation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHU de Nîmes

    RECRUITING

    Nîmes, 30029, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.